Can an MRI detect liver cancer?

Written by Shen Jiang Chao

Radiology

Updated on September 05, 2024

00:00

00:00

Magnetic resonance imaging (MRI) can detect liver cancer. MRI has a high resolution for soft tissues and can multi-dimensionally present the water content and fat content in liver cancer, producing specific signals. MRI can clearly show the size, signal, shape, and the surrounding tissues of liver cancer. It can even detect small liver cancers as tiny as three millimeters and is a preferred method of imaging, more precise than CT.

Other Voices

home-news-image

Written by Zhang Lu

Obstetrics

1min 1sec

home-news-image

Can alpha-fetoprotein diagnose liver cancer?

Alpha-fetoprotein, also known as AFP, reflects the function of the liver and whether there are any diseases present. The accuracy and specificity of alpha-fetoprotein in diagnosing liver cancer are relatively high. In non-pregnant individuals, whether male or female, an elevated alpha-fetoprotein level should raise suspicions of liver disease, and it is advisable to promptly undergo ultrasound or CT scans to determine the presence of liver cancer or other liver diseases. However, during pregnancy, as the fetus grows and develops, a certain amount of alpha-fetoprotein is released. Therefore, when testing the blood of pregnant women, an increase in alpha-fetoprotein is observed. This condition is a physiological change and does not indicate the occurrence of liver diseases such as liver cancer in women. Thus, alpha-fetoprotein can serve as an auxiliary method for diagnosing liver cancer, but only in non-pregnant individuals.

home-news-image

Written by Si Li Li

Gastroenterology

58sec

home-news-image

Can hepatitis B lead to liver cancer?

Hepatitis B can cause chronic infection in the body, which may damage liver cells and potentially lead to liver cirrhosis or liver cancer. Therefore, in cases of hepatitis B virus infection, it is necessary to regularly check liver function and hepatitis B virus DNA. If abnormal transaminase levels are found, timely liver-protective and enzyme-lowering treatments should be administered. If the hepatitis B virus DNA reaches a certain level, antiviral treatment should be initiated to potentially slow the progression of hepatitis B developing into liver cirrhosis or even liver cancer. Additionally, carriers of the hepatitis B virus or patients with hepatitis B should take care to rest adequately, avoid excessive fatigue and staying up late, abstain from alcohol, and maintain a light, digestible diet.

home-news-image

Written by Yan Chun

Oncology

1min 35sec

home-news-image

Will people with early-stage liver cancer experience weight loss?

Patients with early-stage liver cancer generally do not experience weight loss; weight loss is more commonly a clinical manifestation in patients with late-stage liver cancer. The reason for weight loss in liver cancer patients is due to the damage caused by cancerous tissue to liver function, leading to reduced synthesis of albumin. Furthermore, patients with liver cancer often experience a significant decrease in food intake, resulting in insufficient intake of nutrients such as albumin. Additionally, the progression of liver cancer tumors requires the consumption of a large amount of the body's albumin. Therefore, due to these factors, many patients with late-stage liver cancer exhibit clinical manifestations of weight loss. Moreover, besides not experiencing weight loss, patients with early-stage liver cancer also do not typically present with typical clinical symptoms. Many patients are asymptomatic, and as the lesion progresses, the cancer spreads, possibly leading to clinical manifestations associated with tumor spread. For example, pain in the liver area, a significant decrease in food intake, fatigue, fever, pain, and some patients may also exhibit symptoms of metastasis such as headaches, vomiting, abdominal pain, and abdominal distension.

home-news-image

Written by Peng Li Bo

Oncology

43sec

home-news-image

Is primary liver cancer hereditary?

Primary liver cancer is usually not hereditary, but the reason why it tends to appear in families in China is mainly due to the widespread infection of hepatitis B virus, which then leads to a significant correlation with hepatic cirrhosis caused by hepatitis B. It is well known that the hepatitis B virus is contagious and can easily be transmitted within families and from mother to child. Therefore, it is not uncommon to see several cases of liver cancer within the same family, indicating a familial aggregation. Another factor is related to dietary habits, for example, the infection of aflatoxin, which is mainly found in moldy peanuts. If the dietary habits within a family are similar, then, of course, the likelihood of occurrence is certainly higher.

home-news-image

Written by Yan Chun

Oncology

1min 8sec

home-news-image

How to effectively treat advanced liver cancer?

In the late stages of liver cancer, due to the spread of lesions, it is very easy to cause the failure of multiple organs such as the liver, heart, and kidneys, ultimately endangering the patient's life. Therefore, effective treatment methods must be adopted to delay the progression of the disease as much as possible. Currently, effective treatment methods include radiotherapy, chemotherapy, targeted therapy, immunotherapy, traditional Chinese medicine, and some physical therapies. Commonly used clinical treatments include radiofrequency ablation and microwave ablation. Radiotherapy is also a local treatment method, while targeted therapy and chemotherapy immunotherapy are systemic comprehensive treatments. Currently, the effects of targeted therapy for liver cancer are satisfactory, but the effects of chemotherapy and immunotherapy are poor. Most patients need these treatments combined to exert their effective anti-tumor treatment functions.